Todd Creech

Todd A. Creech was the founder of Centice Corp.
(founded in 2003) and held the title of President from 2003 to 2004.
He is currently a Board Member at Magnolia Medical Technologies, Inc. (since 2022), Alcresta Therapeutics, Inc. (since 2017), Everly Well, Inc. (since 2019), ScribeAmerica, Inc. (since 2022), and the Southeast Life Sciences Association.
Mr. Creech has held former positions as a Senior Director at IQVIA, Inc. (2005-2006) and Quintiles, Inc. (California) (2005-2006), Director at BioIQ, Inc. (2018-2022), Executive Director at Starlight Children's Foundation (UK) (1999-2001), Senior Consultant at Andersen Consulting LLP (GB) (1992-1996), Financial Advisor at Femasys, Inc. (2015-2021), Chief Financial Officer & VP-Business Development at SARcode Bioscience, Inc. (2010-2013), Chief Financial Officer at ZS Pharma, Inc. (2013), Principal at SRI International (1996-2000), and Chief Financial Officer at Sirion Therapeutics, Inc. (2010).
Mr. Creech is also a Partner at Healthquest Capital Management Co LLC (2016-2023).
He holds an MBA from Duke University (2003) and an undergraduate degree from Miami University (1991).